The Role of Artificial Intelligence in Advancing the Implementation of the Chemical Weapons Convention

This prestigious event brought together 200 participants from the 193 member states. Dr. Rogers showcased ODP’s cutting-edge expertise in automating the chemical synthesis of raw materials, intermediates, and active pharmaceutical ingredients (APIs). He demonstrated how AI is driving significant progress in accelerating the development and scaling of these manufacturing pathways. Additionally, Dr. Rogers highlighted ODP’s groundbreaking pilot program in agile medicine production at the North Mississippi Healthcare System (NMHS). This initiative successfully produced 12,000 doses of medicines on-demand at the point of care, tailored to meet the specific needs of our partners.